Iron Deficiency clinical trials

Explore recruiting iron deficiency clinical trials.

Recruiting iron deficiency studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Iron Deficiency trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A low-intervention randomised, double-blind, placebo-controlled pilot trial evaluating the feasibility, tolerability and adherence of alternate-day oral Duroferon (ferrous sulphate) in adolescent girls with iron deficiency, and the diagnostic performance of the IRON-5 screening tool (IRONGIRLS-PILOT).

Sweden

Therapeutic use (Phase IV) EU CTIS Study details

Intravenous iron to treat postoperative anaemia in older cardiac surgery patients: a randomized controlled trial (AGE ANAEMIA study)

Netherlands

Therapeutic use (Phase IV) EU CTIS Study details

Tittle: Effects of intravenous administered iron in non-anemic iron deficient patients with colorectal cancer. A double blinded clinical randomized trial.

Denmark

Therapeutic exploratory (Phase II) EU CTIS Study details

A Prospective, Open-Label, Randomized, Interventional Study to Evaluate the Efficacy and Tolerability of Sucrosomial® Iron vs Ferric Maltol in Iron Deficient Women

Spain

Phase III and phase IV (Integrated) EU CTIS Study details

A Phase 3, Randomized, Open-Label, Multicenter Study to Evaluate the Safety, Efficacy and Pharmacokinetics of Ferumoxytol for the Treatment of Iron Deficiency Anemia (IDA) in Pediatric Subjects

Poland, Lithuania

Therapeutic confirmatory (Phase III) EU CTIS Study details

Daily versus alternate day oral iron supplementation for the treatment of iron deficiency anaemia in pregnancy (IronMother)

Ireland

Therapeutic use (Phase IV) EU CTIS Study details

Iron Deficiency trials by city

Iron Deficiency in Toronto Iron Deficiency in Vancouver Iron Deficiency in Montreal Iron Deficiency in Calgary Iron Deficiency in Edmonton Iron Deficiency in Ottawa Iron Deficiency in Winnipeg Iron Deficiency in Quebec City Iron Deficiency in Hamilton Iron Deficiency in Kitchener Iron Deficiency in London Iron Deficiency in Halifax Iron Deficiency in New York Iron Deficiency in Los Angeles Iron Deficiency in Chicago Iron Deficiency in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease